Recombinant TNFRSF4 (Telazorlimab Biosimilar) antibody

Catalog No. ABIN7598027

The Humanized Chimeric anti-TNFRSF4 (Telazorlimab Biosimilar) antibody (ABIN7598027) specifically detects TNFRSF4 (Telazorlimab Biosimilar). The antibody is reactive with Human samples.

Quick Overview for Recombinant TNFRSF4 (Telazorlimab Biosimilar) antibody (ABIN7598027)

Target: TNFRSF4 (Telazorlimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This TNFRSF4 (Telazorlimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-TNFRSF4 (Telazorlimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Telazorlimab Biosimilar Antibody

Specificity: ACT35 antigen, TXGP1L, TAX transcriptionally-activated glycoprotein 1 receptor, Tumor necrosis factor receptor superfamily member 4, TNFRSF4, OX40L receptor, CD134

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 6.9 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for TNFRSF4 (Telazorlimab Biosimilar)

Target: TNFRSF4 (Telazorlimab Biosimilar)

Alternative Name: Telazorlimab Biosimilar

Target Type: Biosimilar

Background: ACT35 antigen, TXGP1L, TAX transcriptionally-activated glycoprotein 1 receptor, Tumor necrosis factor receptor superfamily member 4, TNFRSF4, OX40L receptor, CD134

UniProt: P43489

CAS-No: 2126777-87-3